Exenatide once weekly for the treatment of type 2 diabetes mellitus: clinical results in subgroups of patients using different concomitant medications.
about
Adverse Effects of GLP-1 Receptor AgonistsExenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c < 7%, without weight gain or hypoglycaemia, over 52 weeksPathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies.Once weekly exenatide: efficacy, tolerability and place in therapy.Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: an integrated analysis of the DURATION trials.
P2860
Exenatide once weekly for the treatment of type 2 diabetes mellitus: clinical results in subgroups of patients using different concomitant medications.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Exenatide once weekly for the ...... erent concomitant medications.
@en
Exenatide once weekly for the ...... erent concomitant medications.
@nl
type
label
Exenatide once weekly for the ...... erent concomitant medications.
@en
Exenatide once weekly for the ...... erent concomitant medications.
@nl
prefLabel
Exenatide once weekly for the ...... erent concomitant medications.
@en
Exenatide once weekly for the ...... erent concomitant medications.
@nl
P2093
P2860
P356
P1476
Exenatide once weekly for the ...... erent concomitant medications.
@en
P2093
Byron J Hoogwerf
James Malone
Richard Pencek
Steven C Brunell
P2860
P356
10.3810/PGM.2012.07.2568
P407
P577
2012-07-01T00:00:00Z